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ABSTRACT
Background: Gastric malignancy is the third most common cause of cancer-related death in the world. 
Upper gastrointestinal (UGI) endoscopy for detection of gastric malignancy has been used widely in Indonesia. 
This study aimed to determine the prevalence of gastric malignancy and diagnostic value of UGI endoscopy in 
detection of gastric malignancy in Sanglah Hospital, Denpasar.
Method: A retrospective study on patients undergoing UGI endoscopy in Endoscopy Unit of Sanglah Hospital 
Denpasar between January 2012 and December 2014 was conducted. Endoscopical and histological diagnosis 
ZHUHGRFXPHQWHG7KHGLDJQRVWLFWHVWRIHQGRVFRSLFGLDJQRVLVZHUHFRQGXFWHGE\VKRZLQJLWVVHQVLWLYLW\VSHFL¿FLW\
positive predictive value, negative predictive value, and accuracy.
Results: One thousand and sixty eight patients with upper gastrointestinal symptoms were subjected to endoscopy 
between January 2012 and December 2014. Of the 1068 cases, 39 patients were suspected for gastric malignant 
OHVLRQVRQ8*,HQGRVFRS\'XULQJWKHVWXG\SHULRGKLVWRSDWKRORJLFDOO\FRQ¿UPHGJDVWULFPDOLJQDQF\ZDVIRXQGLQ
SDWLHQWV7KHVHQVLWLYLW\VSHFL¿FLW\SRVLWLYHSUHGLFWLYHYDOXHQHJDWLYHSUHGLFWLYHYDOXHDQGDFFXUDF\RI8*,
endoscopic diagnosis for these neoplastic lesions were 100%, 99.04%, 74.36%, 100%, and 99.06%, respectively.
Conclusion: The prevalence of gastric malignancy was higher compared to western countries. Endoscopy 
is important as diagnostic tool in patients with suspicion of gastric malignancy. Greater suspicion in clinical 
MXGJPHQWDQGFDUHIXOQHVVLQH[FOXGLQJPDOLJQDQF\WKURXJKRQHKLVWRSDWKRORJ\QHJDWLYH¿QGLQJVQHHGWREH
done to reduce the number of misdiagnoses of gastric malignancy.
Keywords: prevalence, gastric malignancy, histopathology, gastric biopsy
ABSTRAK
Latar belakang: Keganasan gaster merupakan penyebab kematian ketiga paling banyak terkait kanker di 
dunia. Endoskopi saluran cerna bagian atas (SCBA) untuk deteksi keganasan gaster telah digunakan secara 
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luas di Indonesia. Penelitian ini bertujuan untuk menentukan prevalensi keganasan gaster dan nilai diagnostik 
endoskopi SCBA dalam deteksi keganasan gaster di Rumah Sakit (RS) Sanglah, Denpasar.
Metode: Suatu penelitian retrospektif dilakukan pada pasien yang dilakukan endoskopi SCBA di Unit 
Endoskopi RS Sanglah Denpasar antara Januari 2012 dan Desember 2014. Diagnosis endoskopis dan histologis 
GLFDWDW8ML GLDJQRVWLN GLDJQRVLV HQGRVNRSLV GLODNXNDQGHQJDQPHQXQMXNNDQ VHQVLWLYLWDV VSHVL¿VLWDV QLODL
prediktif positif, nilai prediktif negatif, dan akurasi.
Hasil: Seribu enam puluh delapan (1068) pasien dengan keluhan pada saluran cerna bagian atas dilakukan 
endoskopi antara Januari 2012 dan Desember 2014. Dari 1068 kasus, 39 pasien diduga terdapat lesi ganas gaster 
SDGDHQGRVNRSL6&%$6HODPDSHULRGHSHQHOLWLDQNHJDQDVDQJDVWHU\DQJGLNRQ¿UPDVLPHODOXLKLVWRSDWRORJL
GLWHPXNDQSDGDSDVLHQ6HQVLWLYLWDVVSHVL¿VLWDVQLODLSUHGLNVLSRVLWLIQLODLSUHGLNVLQHJDWLIGDQDNXUDVL
diagnosis endoskopi SCBA untuk lesi neoplastik ini berturut-turut adalah 100%, 99,04%, 74,36%, 100%, dan 
99,06%.
Simpulan: Prevalensi keganasan gaster lebih tinggi dibandingkan dengan negara-negara Barat. Endoskopi 
penting sebagai alat diagnostik pada pasien dengan dugaan keganasan gaster. Kewaspadaan dalam penilaian 
klinis dan kehati-hatian dalam mengeksklusi keganasan berdasarkan pemeriksaan histopatologi yang negatif 
perlu dilakukan untuk mengurangi jumlah kesalahan diagnosis keganasan gaster.
Kata Kunci: prevalensi, keganasan gaster, histopatologi, biopsi gaster
INTRODUCTION
Nearly one million new cases of gastric malignancy 
ZHUHHVWLPDWHGWRRFFXULQPDNLQJLW WKH¿IWK
most commonly diagnosed cancer in the world.1 
Gastric malignancy itself remains a global killer being 
the world’s third commonest cause of death from 
malignant disease.1,2 Global Burden of Cancer Study 
(GLOBOCAN) estimates that 723,000 cancer related 
deaths occurred worldwide in 2012 were caused by 
gastric malignancy.1 More than 70% of the world’s new 
cases occur in developing countries, and half of the 
world total occurs in Asia. World Health Organization 
South-East Asia Region (WHO SEARO) recorded 
91,000 new cases of gastric cancer in 2012, 6,000 
(6.6%) of them were from Indonesia. Although the 
incidence of gastric cancer in Indonesia is very low, 
gastric cancer may resulted in 5,400 deaths in 2012.1 
Due to high rate of mortality, accurate diagnostic study 
is necessary in order to establish early diagnosis.
Endoscopy has facilitated early diagnosis of 
patients with upper gastrointestinal (UGI) malignancy 
and provided modalities in obtaining samples for 
histological diagnosis of gastric cancer.3 It has widely 
known that the endoscopic appearances highly 
suggestive but not pathognomonic and needs further 
KLVWRORJLFDOFRQ¿UPDWLRQ7KHGLDJQRVWLFDFFXUDF\IRU
detection of gastric cancer are varied among studies, 
ranging from 86-97.4%.4,5 For the distinction between 
malignant and non-malignant lesion, histological 
evaluation remains the gold standard.6 Therefore, we 
aim to determine the prevalence of gastric malignancy 
and diagnostic value of UGI endoscopy in detection 
of gastric malignancy in Sanglah Hospital, Denpasar.
METHOD
This is a retrospective analytical study of UGI 
endoscopy conducted on patients in Endoscopy Unit 
of Sanglah Hospital Denpasar between January 2012 
and December 2014. Inclusion criteria were all patients 
with dyspepsia, heartburn, or history of gastrointestinal 
bleeding. Exclusion criteria were patients under 17 years 
old and patients with documented chronic liver disease.
Endoscopy was done by using flexible video 
endoscope (Olympus Exera II GF-170). On endoscopy, 
gastrointestinal lesions were visualized. Details of 
the site, extent, and type of the lesion were recorded. 
After visualization of the lesion, biopsies were 
retrieved by using forceps. Two biopsies were taken 
for non-malignant lesion, and 6 biopsies for malignant 
lesion. Biopsies were transferred to a container 
bottle containing 10% formalin buffer, labelled with 
patient’s identity, immediately after the biopsies 
were obtained. Biopsy tissues then processed and cut 
by using microtome until 4-5 series of slides were 
resulted. Slides were stained routinely with Giemsa. 
The histopathological interpretations were derived 
according to WHO classification.6 Biopsies were 
interpreted as negative and positive for malignancy. 
Malignant lesion were interpreted as a well-demarcated 
lesion and irregularity in color/surface pattern. 
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0DOLJQDQW XOFHUZHUH GH¿QHG DV DQ XOFHUDWHGPDVV
with nodular looking folds and irregular overhanging, 
nodular margin.
SPSS 17 was used in statistical analysis of this 
study. Age was summarized as mean and standard 
deviation (SD). Sex was presented as counts and 
percentages. Using histological examination as the 
gold standard for diagnosis of gastric malignancy, we 
FDOFXODWHG VHQVLWLYLW\ VSHFL¿FLW\SRVLWLYHSUHGLFWLYH
value (PPV), negative predictive value (NPV), and 
accuracy by generating 2 x 2 tables.
RESULTS
Between January 2012 and December 2014,1478 
underwent UGI endoscopy. Three hundred and ten 
patients were excluded because of documented chronic 
liver disease or had age less than 17 years old. One 
thousand and sixty eight patients were included in this 
study. Mean age of patients was 51.24 ± 15.14 years. 
There were 614 (57.49%) males and 454 (42.51%) 
females. Thirty nine (39) out of 1068 patients with 
endoscopically proven gastric malignancy were 
LGHQWL¿HG2QKLVWRSDWKRORJLFDOH[DPLQDWLRQELRSVLHV
were positive for malignancy in 29 (2.72%) cases and 
negative in 10 cases. Majority of the lesions were 
found in the antrum (51.28%), 14 (35.9%) in the body, 
2 (5.13%) in the cardia, and 3 (7.69%) were diffuse. A 
histological diagnosis of gastric cancer was established 
in 29 (74.36%) patients. In 10 (25.64%) patients the 
histology was negative for malignancy (Table 1, Figure 
1). Eighteen out of 29 (62%) patients were less than 
55 years old (Figure 2).
Out of the 39 cases diagnosed as probable gastric 
malignancy endoscopically, 29 were found to be 
malignant and 10 were negative for malignancy (Table 
7KHVHQVLWLYLW\VSHFL¿FLW\SRVLWLYHSUHGLFWLYHYDOXH
and negative predictive value were shown in table 3.
7DEOH  (QGRVFRSLFDO DQG KLVWRORJLFDO ¿QGLQJV LQ VWXG\
SRSXODWLRQ
Criteria n (%)
Upper GI endoscopy
No malignancy 995 (93.16%)
Esophageal malignancy 18 (1.69%)
Gastric malignancy 39 (3.65%)
Duodenal malignancy 16 (1.5%)
Gastric cancer histology
Adenocarcinoma 20 (51.28%)
Signet ring cell carcinoma 6 (15.38%)
Others (GIST, MALT lymphoma)
Negative for malignancy
3 (7.7%)
10 (25.64%)
Gastric cancer location
Cardia 2 (5.13%)
Corpus 14 (35.9%)
Antrum 20 (51.28%)
Diffuse 3 (7.69%)
GIST: gastrointestinal stromal tumor; MALT: mucosal-associated lymphoid tissue
)LJXUH6XVSHFWHGJDVWULFFDQFHUKLVWRORJ\
)LJXUH*DVWULFFDQFHUDJHJURXS
7DEOH&RPSDULVRQRIHQGRVFRSLFDODQGKLVWRORJLFDO¿QGLQJV
in gastric malignancy
Endoscopic 
diagnosis
Histopathological diagnosis
Positive for 
malignancy
Negative for 
malignancy
Probable malignancy 29 10
Not malignancy 0 1029
Total 29 1039
Table 3. Diagnostic test of endoscopy in diagnosing gastric 
malignancy
Diagnostic test n (%)
Sensitivity 100%
6SHFL¿FLW\ 99.04%
Positive predictive value 74.36%
Negative predictive value 100%
Accuracy 99.06%
DISCUSSION
Although the prevalence of gastric cancer has been 
declining over several decades, it still represents major 
health problem.1 By knowing the prevalence, physician 
may build awareness towards gastric cancer. In this 
VWXG\SUHYDOHQFHRIJDVWULFPDOLJQDQF\FRQ¿UPHGE\
histopathological study was 2.72%. Among patients in 
Western Countries who had endoscopic evaluations, 
gastric carcinoma were found in 1-2% of cases.7 
However, this number is higher in Asia. Study in 
Cipto Mangunkusumo hospital showed prevalence of 
2.98%.8  Malignancy was noted in 3.5% of the total 
3,432 patients performing endoscopy in India.9 Study 
in East Asian Countries showed more dramatic results, 
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performed by Bai et al which generate prevalence of 
4.25%.10
This study also showed that 62% of gastric cancer 
patients were < 55 years old. The increased frequency 
of gastric cancer patients younger than traditional cut-
off for alarm signs showed that increased surveillance 
on younger age group need to be taken. Study in Jakarta 
from 2007-2011 showed that there was shifting toward 
\RXQJHUDJH7KLVFRQGLWLRQPD\UHÀHFWDQLQFUHDVHG
health awareness of patients, increased number of 
endoscopists and endoscopic facilities in Indonesia.11
Macroscopic appearance in endoscopy has shown 
high probability of gastric malignancy. However, there 
has been few reports of studies questioning the accuracy 
of endoscopy.4,5 In the current study, we found that 
overall accuracy rate of endoscopic biopsy calculated 
for all patients was 99.06%. Tatsuta et al calculated 
the accuracy of endoscopic biopsy in diagnosis of 
malignancies of the upper GI tract and gave 97.4% as 
the result.5 Like our result, this study clearly indicate 
that endoscopic biopsy is a very reliable method for 
the early diagnosis of gastric cancer.
This study found 10 (0.94%) false-negative 
diagnoses of malignancy among 1,068 patients who 
underwent UGI endoscopy. There are multiple factors 
that may caused misdiagnosis of gastric cancer. In a 
study conducted by Pailoor et al, 2 out of 23 (9.7%) 
endoscopically suspected gastric malignancy were 
proven to be chronic gastritis and 8 out of 14 (57.12%) 
benign gastric ulcer found on endoscopy were 
adenocarcinoma when examined by pathologists.12 
The difference between endoscopy and histology 
¿QGLQJVPD\EHFDXVHGE\QRQUHSUHVHQWDWLYHPDWHULDO
Aslan et al in a case report of an UGI malignancy 
stated that large lesion size and the small sample 
taken via the endoscopic biopsy forceps may result in 
inaccurate diagnosis.13 Other reason stated by Tatsuta 
et al that may caused low accuracy in diagnosing 
gastric malignancy was that the cancer tissues were 
usually covered by normal gastric mucous, and when 
ELRSV\VSHFLPHQVZHUHWRRVPDOODQGWRRVXSHU¿FLDO
PDOLJQDQWWLVVXHVZHUHGLI¿FXOWWRREWDLQ7KHUHIRUH
LWZDVVXJJHVWHGWKDWVXSHU¿FLDOHURVLRQVRUVKDOORZ
ulcerations may serve as the most suitable target sites 
for biopsy.5
Medication used for relieving dyspeptic symptoms 
may also cause false-negative diagnosis. Most patients 
in this study had proton pump inhibitors prior to 
endoscopy. Use of the powerful acid suppressing 
agents such as proton pump inhibitors and H2 receptor 
antagonists can mask endoscopic signs of early gastric 
cancer. This condition resulted from mucosal healing of 
lesion, especially in early gastric cancer. The improved 
mucosal lesion may also covered malignant tissue 
when biopsied.14
In order to reduce false-negative diagnosis, Amin 
et al recommended to take multiple biopsies and for 
gastric ulcers these should be obtained from both the 
rim and base.15 Recommendations on the optimum 
number of biopsies differ but some studies noted 
that the greater the biopsy number performed, the 
more accurate the diagnosis of UGI malignancy.15,16,17 
*UDKDP HW DO VWDWHG WKDW WKH ¿UVW ELRSV\ VSHFLPHQ
yielded a correct diagnosis in 70% of gastric 
carcinomas while a total of seven biopsy specimens 
yielded greater than 98%.16 Other study suggested 
at least 6 biopsy specimens should be taken from 
suspected malignant gastric lesions to obtain diagnostic 
accuracy of 100%.17,18 However, multiple biopsies 
posed some issues need to be remembered, such as high 
tendency to post procedure bleeding, increased time 
taken on endoscopy, and extra hour for examination 
by pathologists.19
Some techniques may also be used in obtaining 
malignant tissue, such as brushing, aspiration, 
suction, salvage, and imprint cytology to improve 
the diagnostic yield of biopsy specimens in UGI 
malignancies.12 7KHVHPD\EHGRQHLQVRPHGLI¿FXOW
gastric malignancy, especially those located in sub 
PXFRXV6XEPXFRXVWXPRUVSUHVHQWVRPHGLI¿FXOWLHV
LQ WKHLU GLDJQRVLV HVSHFLDOO\ EHFDXVH LWV GH¿QLWLYH
GLDJQRVLVQHHGVKLVWRORJLFFRQ¿UPDWLRQ,QRXUVWXG\
biopsy samples were only obtained by using forceps 
and only limited to the covering mucous. Kojima et 
al used endoscopic resection for lesions originating in 
the muscularis mucosa or submucous.20
This study has several implications. First, UGI 
endoscopy still remain important modality in 
diagnosing malignancy and therefore need to be 
distributed throughout every district hospital as 
screening tool. Second, several important factors such 
as evaluation of the clinical data, supporting laboratory 
or imaging data, experience in choosing appropriate 
biopsy number and site, proper processing of biopsy 
tissue and meticulous report by the histopathologist for 
interpretation of endoscopic biopsies may be noticed in 
establishing diagnosis of gastric malignancy. Diagnosis 
FDQ¶WEHH[FOXGHGE\RQO\RQHQHJDWLYH¿QGLQJVRQ
histopathology, therefore follow-up endoscopy may 
be needed. Endoscopy is an informative tool with 
KLJK VHQVLWLYLW\ DQG VSHFL¿FLW\ WR GLDJQRVH JDVWULF
malignancy.
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CONCLUSION
Gastric cancer was found to be high compared 
to Western Countries. Endoscopy is important as 
diagnostic tool in patients with suspicion of gastric 
malignancy. Greater suspicion and more rigorous 
protocol in endoscopy and biopsy must be implemented 
in order to reduce the number of missed diagnoses of 
UGI malignancy.
REFERENCES
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers 
C, et al. Globocan 2012 v1.0. Cancer incidence and mortality 
worldwide: IARC cancer base No. 11. International Agency 
for Research on Cancer [serial online] 2013 [cited 2015 Feb 
1]. Available from: URL: http://globocan.iarc.fr.
2. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk 
factors. J Clin Epidemiol 2003;56:1-9.
3. Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, 
Leighton JA, et al. ASGE guideline: the role of endoscopy in 
the surveillance of premalignant conditions of the upper GI 
tract. Gastro intest Endosc 2006;63:570-80.
4. Jorde R, Ostensen H, Bostad LH, Burhol PG, Langmark FT. 
Cancer detection in biopsy specimens taken from different 
types of gastric lesions. Cancer 1986;58:376-82.
5. Tatsuta M, Iishi H, Okuda S, Oshinia A, Taniguchi H. 
Prospective evaluation of diagnostic accuracy of gastro 
¿EHU VFRSLF ELRSV\ LQ GLDJQRVLV RI JDVWULF FDQFHU&DQFHU
1989;63:1415-20.
6. :RUOG+HDOWK2UJDQL]DWLRQ FODVVL¿FDWLRQ RI WXPRXUV ,Q
Hamilton SR, Aaltonen LA, eds. Pathology and Genetics 
of Tumours of the Digestive System. Lyon: IARC Press 
2000.p.37-52.
7. Sundar N, Muraleedharan V, Pandit J, Green JT, Crimmins 
R, Swift GL. Does endoscopy diagnose early gastrointestinal 
cancer in patients with uncomplicated dyspepsia?.Post grad 
Med J 2006;82:52-4.
8. Yusuf AI, Syam AF, Abdullah M, Makmun D, Simadibrata 
M, Manan C, et al. Upper gastrointestinal malignancy among 
dyspepsia patients in Cipto Mangunkusumo Hospital Jakarta. 
Indones J Gastroenterol Hepatol Dig Endosc 2009;10:92-5.
9. Sumathi B, Navaneethan U, Jayanthi V. Appropriateness of 
indications for diagnostic upper gastrointestinal endoscopy in 
India. Singapore Med J 2008;49:970-6.
10. Bai Y, Li ZS, Zou DW, Wu RP, Yao YZ, Jin ZD, et al. 
Alarm features and age for predicting upper gastrointestinal 
malignancy in Chinese patients with dyspepsia with high 
background prevalence of Helicobacter pylori infection 
and upper gastrointestinal malignancy: an endoscopic 
database review of 102,665 patients from 1996 to 2006. Gut 
2010;59:722-8.
11. Makmun D, Simadibrata M, Abdullah M, Syam AF, Fauzi 
A, Renaldi K, et al. Changing trends in gastrointestinal 
malignancy in Indonesia: The Jakarta experience. J Cancer 
Res Ther 2014;2:160-8.
12. Pailoor K, Sarpangala MK, Naik RCN. Histopathologic 
diagnosis of gastric biopsies in correlation with endoscopy – a 
study in tertiary care center. Adv Lab Med Int 2013;3:22-31.
13. Aslan S, Cetin B, Markoc F, Cetin A. A duodenal villous 
adenoma associated with in situ carcinoma: A case report. 
Turk J Cancer 2001;31:162-7.
14. Suvakovic Z, Bramble MG, Jones R, Wilson C, Idle N, Ryott 
J. Improving the detection rate of early gastric cancer requires 
PRUH WKDQRSHQDFFHVVJDVWURVFRS\D¿YH\HDU VWXG\*XW 
1997;41:308-13.
15. Amin A, Gilmour H, Graham L, Paterson-Brown S, Terrace 
J, Crofts TJ. Gastric adenocarcinoma missed at endoscopy. J 
R Coll Surg Edinb 2002;47:681-4.
16. Graham DY, Schwartz JT, Cain GD, Gyorkey.Prospective 
evaluation of biopsy number in the diagnosis of esophageal 
and gastric carcinoma. Gastroenterology 1982;82:228-31.
17. Lal N, Bhasin DK, Malik AK, Gupta NM, Singh K, Mehta 
SK. Optimal number of biopsy specimens in the diagnosis of 
carcinoma of the oesophagus. Gut 1992;33:724-6.
18. Misumi A, Mori K, Ikeda T, Misumi K, Ookubo F, Shimamoto 
M, et al. Evaluation of fibergastroscopic biopsy in the 
diagnosis of gastric cancer. A study of 339 cases. Gastroenterol 
J pn 1978;13:255-63.
19. Choi Y, Choi HS, Jeon WK, Kim BI, Park DI, Cho YK, et 
al. Optimal number of endoscopic biopsies in diagnosis of 
advanced gastric and colorectal cancer. J Korean Med Sci 
2012;27:36-9.
20. Kojima T, Takahashi H, Parra-Blanco A, Kohsen K, Fujita 
R. Diagnosis of submucosal tumor of the upper GI tract by 
endoscopic resection. Gastro intest Endosc 1999;50:516-22.
